Kiryat Bialik, Israel

Evgeni Flyaks

This inventor holds 2 USPTO granted patents. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2006-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evgeni Flyaks. Retrieved from https://idiyas.com/inventor/evgeni-flyaks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Evgeni Flyaks: Innovator in Pharmaceutical Chemistry

Introduction

Evgeni Flyaks is a notable inventor based in Kiriat-Bialik, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes related to valsartan, a medication used to treat high blood pressure.

Latest Patents

Evgeni Flyaks holds 2 patents that showcase his innovative work. His latest patents include a process for the preparation of valsartan and its intermediates, which provides methods for synthesizing this important compound. Additionally, he has developed polymorphs of valsartan, offering both crystalline and amorphous forms along with the processes for their preparation.

Career Highlights

Flyaks is currently employed at Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on advancing pharmaceutical formulations and improving drug delivery systems.

Collaborations

Throughout his career, Evgeni has collaborated with talented professionals in the industry, including Igor Rukhman and Ben-Zion Dolitzky. These collaborations have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Evgeni Flyaks is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in medication preparation. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…